IVISense™ Acute Vascular (Genhance™) fluorescent probes enable imaging and quantitation of acute vascular permeability increase, bladder clearance via intravital ureter imaging, or incorporation into liposomes for drug delivery monitoring.
For research use only. Not for use in diagnostic procedures.
true false
IVISense Acute Vascular 750 fluorescent probe is small molecule near infrared fluorescent agent designed for in vivo preclinical intravenous (IV) administration. This probe, being of low molecular weight, rapidly leaks into regions of increased vascular permeability that can occur due to cancer or inflammation. In addition, its rapid clearance from the blood allows early imaging of the bladder or ureters for basic research or for surgical imaging approaches in small and large animals. The physical/chemical properties of this probe also makes it useful for encapsulation into nanoparticles or liposomes as a reporter system for drug delivery approaches.
This fluorescent probe is available in a 5 mg size.
| Fluorescent Agent Type | Vascular |
|---|---|
| Optical Imaging Classification | Fluorescence Imaging |
| Product Brand Name | IVISense |
| Quantity in a Package Amount | 1.0 Units |
| Shipping Condition | Ambient |
| Unit Size | 5 mg |
| Wave Length | 750 nm |
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And ...
Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into disease processes and treatment effects. Designing an effective study from the beginning can help save time and resources.
Learn about several important best p ...
The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.
This s ...
The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick ...
